INTRODUCTION
Vitiligo is a dyschromia marked by the onset of lesions of different shapes and sizes, as a result of melanocyte destruction. It affects men and women of various ethnic groups equally, reaching around 2% of the global population.
1,2 There are several therapeutic alternatives for the treatment of vitiligo, including topical and oral agents, phototherapy, laser and surgical procedures. Patients who are resistant to other treatments may benefit from surgical treatments, which consist in transplantation of cutaneous tissue or cell suspension applied to the affected areas.
3 The method of non-cultured melanocytes/keratinocytes (melanocyte cell suspension) transplantation consists in the separation of epidermal cells from a donor site and their appli-cation to depigmented recipient areas. The results depend on some factors such as the shape and stability of vitiligo, phototype and anatomic location of lesions.
CASE REPORT Methodology
The patients selected for transplantation presented vitiligo with a minimum stability of one year. The technique used was described by Mulekar in 2005. 4 The donor site (upper thigh region) was anesthetized and a thin skin layer was removed by shaving with a flexible blade (Crystalia), placed on a Petri dish containing 0.2% trypsin solution (Cultilab) and incubated for 30 minutes at 37 0 C. After washing with DMEM/F-12 medium (Cultilab) the epidermis was separated from the dermis, fragmented into smaller pieces, transferred to a tube containing the same medium and centrifuged for 6 min. at 2000 rpm. The cell pellet was resuspended in an 1 mL syringe. The recipient area was submitted to low-speed dermabrasion. The cell suspension was then uniformly spread and the area was covered with a collagen dressing (Neuskin-F, Medira, UK) and Tegaderm. The patient was discharged and the dressing removed after one week. Only one session was carried out with each patient.
Case 1
A male patient, 41 years old, driver. Previously submitted to surgical reconstruction and insertion of a prosthesis to replace the eye lost in an automobile accident. After the surgery, he noticed the onset of a depigmented macule in the periorbital region, which was diagnosed as localized segmental vitiligo. Topical treatment was started with corticosteroids, viticromin and excimer laser (17 sessions), with discreet improvement (5%). He was referred for melanocyte transplantation, which was performed on the lesion in the left periorbital region ( Figure 1A) . Two months after the transplant a 60% improvement in repigmentation was observed during patient assessment and photographic evidence ( Figure 1B ). Four months later there was an increase in repigmentation (75%) of the treated area, resulting in an excellent degree of patient satisfaction ( Figure 1C ).
Case 2
A male patient, 35 years old, presented generalized acrofacial vitiligo, with several lesions on the hands, feet and frontal region. A previous treatment with psoralene and sun exposure did not improve lesions significantly. He was submitted to melanocyte suspension transplantation for treatment of frontal region lesions (Figure 2A) . Three months later a 90% improvement in repigmentation was observed, measured by photographic assessment, with excellent uniformity of color ( Figure 2B ). The patient demonstrated a high degree of satisfaction and desire to have further transplant sessions to treat other affected areas. 
